Connect to share and comment

U.S. FDA approves Biogen's hemophilia B drug Alprolix

By Toni Clarke (Reuters) - Biogen Idec Inc has won U.S. approval for its long-acting hemophilia B treatment Alprolix, the U.S. Food and Drug Administration said on Friday. Hemophilia B is a rare, inherited disorder in which a person's blood does not clot properly, which can lead to prolonged bleeding and bruising. It affects about 4,000 people in the United States and 25,000 worldwide.

Fly brain 'atlas' opens door to linking human neurons to actions

By Sharon Begley NEW YORK (Reuters) - Research unveiled on Thursday identifies the brain neurons that cause every behavior fruit fly larvae execute, raising the tantalizing possibility that neuroscientists will be able to construct a similar "atlas" in people.

Tennis: D-backs pitcher Corbin undergoes surgery

Arizona Diamondbacks all-star left-handed pitcher Patrick Corbin underwent surgery Tuesday to repair a damaged left elbow ligament, the Major League Baseball team announced. Corbin exited his pre-season game on March 15 with what was called forearm stiffness and an MRI after the game showed ulnar collateral ligament damage, a sign that a tendon replacement operation, known as Tommy John surgery, was needed. Typically, a year is needed to recover from the operation.

US treasury secretary undergoes prostate treatment

US Treasury Secretary Jacob Lew was treated Tuesday for a benign enlarged prostate and expects to be back at work next week, a Treasury spokeswoman said. "Secretary Lew's outpatient surgical procedure went well and as planned today," said spokeswoman Natalie Earnest in an email. "The secretary is now resting comfortably and continues to expect to resume his normal schedule in Washington next week." Lew, 58, fell ill during a visit to Mexico City on March 18 and was taken to hospital there for what was called then a "minor medical issue". pmh/rcw

FDA staff review recommends against Novartis heart failure drug

By Toni Clarke WASHINGTON (Reuters) - A drug to treat acute heart failure made by Novartis AG should not be approved because there is insufficient evidence to show it improves symptoms, according to an initial review by the U.S. Food and Drug Administration. The review, posted on the FDA's website on Tuesday, comes two days ahead of a meeting of outside advisors who will make their own recommendation on whether the drug should be approved. The FDA is not obliged to follow the advice of its advisory panels but typically does so.

US treasury secretary to undergo prostate surgery

US Treasury Secretary Jacob Lew will undergo surgery Tuesday in New York to treat a benign enlarged prostate. The outpatient procedure will keep him at home for the rest of the week, after which he should be able to resume duties, a spokeswoman said Sunday. Eight days before the scheduled operation, Lew was treated at a Mexico City hospital for what the Treasury called "a minor medical issue." Lew, 58, has served as treasury secretary for the past year after replacing Timothy Geithner in early 2013. lo-vmt/bfm/jm

UK cost agency says 'no' to Bayer prostate cancer drug Xofigo

LONDON (Reuters) - Britain's healthcare cost agency has recommended against using Bayer's new prostate cancer drug Xofigo on the state health service because the German firm did not provide evidence on how well it worked compared to other therapies. The draft guidance from the National Institute for Health and Care Excellence (NICE), issued on Monday, is now subject to consultation.

Treasury's Lew to undergo treatment for enlarged prostate

WASHINGTON (Reuters) - Treasury Secretary Jack Lew will have an outpatient surgical procedure in New York on Tuesday for treatment of a benign enlarged prostate, the Treasury Department said on Sunday. Lew expects to stay at home in New York for the rest of the week, and "his physician expects that he will be able to return to his full schedule next week," Treasury spokeswoman Natalie Wyeth Earnest said in a statement.

Ontario vows to shut down private clinics that pay for blood plasma donations

TORONTO - Ontario Health Minister Deb Matthews vowed Tuesday to shut down any private clinics that pay people to donate blood plasma, accusing one firm of targeting the poor. Canadian Plasma Services was told it would not be given a licence by the province to open clinics in Toronto and Hamilton that would pay people $25 to donate plasma, said Matthews. "If you look at where they're located, there's no question that they’re going into low-income neighbourhoods," she said. "It's very clear what their business model is."

Heart maker Carmat to wait before next transplant: founder

By John Irish PARIS (Reuters) - French artificial heart maker Carmat will not carry out any more human transplants until it has determined the cause of the death of the first patient fitted with its device, one of the company's co-founders said on Sunday. Carmat's first patient, a 76-year-old man, died on March 2 in Paris, two and a half months after his operation.
Syndicate content